UP!

XONE $26.7

XONE target price
26.70
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2021 2022-03-14 Future report Set alerts
Q3 2021 2021-11-11 0.00 0.00
Q2 2021 2021-08-11 -0.25 -0.25
Q1 2021 2021-05-17 -0.29 -0.29
Q4 2020 2021-03-11 -0.21 -0.21
Q3 2020 2020-11-05 0.00 0.00
Q2 2020 2020-08-06 -0.24 -0.24
Q1 2020 2020-05-07 -0.22 -0.22
Q4 2019 2020-03-12 -0.12 -0.12
Q3 2019 2019-11-07 -0.30 -0.30

Ratings

2016-06-05 Reiterated Rating Pacific Crest Sector Perform
2016-05-24 Initiated Coverage FBR & Co. Outperform $14.00
2016-05-24 Initiated Coverage FBR & Co Outperform $14.00
2016-05-12 Reiterated Rating Brean Capital Hold
2016-05-12 Reiterated Rating Canaccord Genuity Hold
2016-05-11 Reiterated Rating Stifel Nicolaus Hold
2016-04-01 Reiterated Rating Jefferies Group Hold
2016-03-28 Reiterated Rating Pacific Crest Equal Weight
2016-03-28 Downgrade Imperial Capital In-Line to Underperform $8.00 to $9.00
2016-03-24 Reiterated Rating Brean Capital Hold
2016-03-24 Reiterated Rating Canaccord Genuity Hold
2016-01-13 Reiterated Rating Oppenheimer Outperform $14.00
2016-01-13 Reiterated Rating Oppenheimer Holdings Inc. Outperform $14.00
2015-12-10 Reiterated Rating Stephens Hold
2015-11-11 Reiterated Rating Canaccord Genuity Hold $9.00
2015-11-10 Reiterated Rating Oppenheimer Outperform
2015-09-09 Initiated Coverage Imperial Capital In-Line $8.00
2015-08-14 Reiterated Rating Pacific Crest Equal Weight
2015-08-12 Lower Price Target Credit Suisse Underperform $15.00 to $14.00
2015-08-12 Lower Price Target Oppenheimer Outperform $27.00 to $14.00
2015-08-12 Lower Price Target Credit Suisse Group AG Underperform $15.00 to $14.00
2015-08-11 Reiterated Rating Canaccord Genuity Hold $9.00
2015-07-02 Reiterated Rating Stifel Nicolaus Neutral
2015-06-26 Reiterated Rating Canaccord Genuity Hold $13.00
2015-06-14 Reiterated Rating Canaccord Genuity Hold $13.00
2015-06-12 Lower Price Target Credit Suisse Underperform $18.00 to $15.00
2015-06-12 Reiterated Rating Stifel Nicolaus Neutral
2015-06-12 Reiterated Rating Stephens Equal Weight $22.00 to $16.00
2015-06-12 Reiterated Rating Brean Capital Hold
2015-06-12 Reiterated Rating Deutsche Bank Hold $22.00 to $15.00
2015-06-12 Reiterated Rating Deutsche Bank AG Hold $22.00 to $15.00
2015-06-05 Initiated Coverage FBR & Co. Outperform to Market Perform $37.00 to $13.00
2015-03-18 Reiterated Rating Brean Capital Hold
2015-03-18 Reiterated Rating Canaccord Genuity Hold $17.00
2015-03-17 Reiterated Rating Oppenheimer Buy
2015-03-17 Reiterated Rating Nomura Outperform to Market Perform $37.00 to $17.00
2015-03-17 Downgrade FBR & Co. Outperform to Market Perform $37.00 to $17.00
2015-03-17 Reiterated Rating Nomura Holdings Inc. Outperform to Market Perform $37.00 to $17.00
2015-01-06 Initiated Coverage Credit Suisse Underperform $18.00
2014-11-14 Reiterated FBR Capital Outperform $45 to $37
2014-11-14 Reiterated Rating Jefferies Group Hold $30.00 to $21.00
2014-11-14 Lower Price Target Credit Suisse Underperform $21.00 to $18.00
2014-11-14 Lower Price Target FBR & Co. Outperform $45.00 to $37.00
2014-10-21 Initiated Coverage Oppenheimer Outperform $35.00
2014-08-29 Initiated Stifel Hold
2014-08-29 Initiated Coverage Stifel Nicolaus Hold $29.00
2014-08-15 Reiterated Rating Credit Suisse Underperform $25.00 to $21.00
2014-08-15 Reiterated Rating Jefferies Group Hold $32.00 to $30.00
2014-08-15 Initiated Coverage FBR & Co. Outperform $55.00 to $45.00
2014-08-15 Reiterated Rating Canaccord Genuity Hold $30.00 to $28.00
2014-06-20 Downgrade Jefferies Group Buy to Hold $50.00 to $32.00
2014-06-19 Initiated Brean Capital Hold
2014-06-18 Initiated Coverage Brean Capital Hold
2014-05-16 Reiterated FBR Capital Outperform $66 to $55
2014-05-16 Reiterated Rating Jefferies Group Buy $58.00 to $50.00
2014-05-16 Lower Price Target Canaccord Genuity $43.00 to $30.00
2014-05-16 Lower Price Target Deutsche Bank Hold $45.00 to $27.00
2014-05-16 Downgrade Stephens Overweight to Equal Weight
2014-05-16 Lower Price Target FBR & Co. Outperform $66.00 to $55.00
2014-05-15 Lower Price Target Credit Suisse $37.00 to $25.00
2014-03-31 Upgrade BB&T Capital Mkts Hold to Buy
2014-03-31 Upgrade BB&T Corp. Hold to Buy $50.00
2014-03-20 Lower Price Target Deutsche Bank $45.00
2014-01-15 Reiterated Rating Jefferies Group Buy
2014-01-15 Downgrade Canaccord Genuity Buy to Hold $75.00 to $55.00
2014-01-13 Reiterated Rating Deutsche Bank Hold $55.00 to $65.00
2013-12-10 Initiated Coverage Jefferies Group Buy $72.00
2013-12-09 Initiated Coverage Deutsche Bank Hold $55.00
2013-12-09 Initiated Coverage Pacific Crest Sector Perform
2013-11-15 Boost Price Target Janney Montgomery Scott Buy $70.00 to $75.00
2013-10-08 Initiated Coverage Janney Montgomery Scott Buy $70.00
2013-10-07 Reiterated Rating FBR & Co. Outperform to Positive $75.00
2013-09-20 Resumed FBR Capital Outperform $75
2013-09-20 Initiated Coverage FBR & Co. Outperform $75.00
2013-09-17 Initiated Coverage Credit Suisse Underperform $48.00
2013-07-15 Downgrade BB&T Capital Mkts Buy to Hold
2013-06-06 Initiated Canaccord Genuity Buy $55
2013-05-22 Reiterated FBR Capital Outperform $35 to $50
2013-04-01 Reiterated FBR Capital Outperform $32 to $35
2013-03-04 Initiated BB&T Capital Mkts Buy $34
2016-06-05 Reiterated Rating Pacific Crest Sector Perform
2016-05-24 Initiated Coverage FBR & Co. Outperform $14.00
2016-05-24 Initiated Coverage FBR & Co Outperform $14.00
2016-05-12 Reiterated Rating Brean Capital Hold
2016-05-12 Reiterated Rating Canaccord Genuity Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
ROCKWELL S KENT Chair and CEO 29.15%  (4210555) XONE /
Novel Century Ventures Ltd 9.68%  (1397764) XONE /
Burns David J President and COO 1.79%  (259000) XONE /
Hoechsmann Rainer GM of ExOne GmbH 1.53%  (221000) XONE /
Smith Brian W Chief Financial Officer 0.32%  (46700) XONE /
Lyons Dillon JoEllen Chief Legal Officer & Sec\'y 0.31%  (45000) MYL / XONE /
SACK HANS J 0.29%  (41500) XONE /
Lucas Rick Chief Technology Officer 0.24%  (35000) XONE /
SEMPLE LLOYDE A 0.21%  (29750) XONE /
WACHTEL BONNIE K 0.15%  (21000) VSEC / XONE /
Strome William Frederick 0.13%  (18500) FBRC / RTI / XONE /
Kilmer Raymond J 0.12%  (17250) XONE /
Pashke Gregory F 0.09%  (13250) XONE /
Sellier Victor F 0.09%  (12750) XONE /
IRVIN JOHN Chief Financial Officer 0.07%  (10000) XONE /